Drug eluting stents not cost effective for low risk patientsBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7627.962-a (Published 08 November 2007) Cite this as: BMJ 2007;335:962
In general, drug eluting stents aren't good value for money⇑. They are more expensive than bare metal stents, and European researchers recently estimated that if every patient had one, each cardiac event averted over 18 months would cost an extra €64 732 (£45 000; …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial